Arcturus Therapeutics Holdings Inc. Common Stock
XNAS:ARCT
6.79
$8.40 - 1.00
$5.02 - 100.00
$6.75
$6.9
$6.83
$6.8
24.17
5.85
299130
1030526
26020082.26
Chart
TendieTensor AI Analysis
Company
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
Fundamentals
176
-2.760000
0.823505
-0.49
100
BBG00NNW8JK1
BBG00NNW8JL0
27.15M
27.15M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ARCT. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.